Novo Nordisk CSO on New Obesity Shot Results and Drug Pipeline
Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company's weight loss obesity ...
Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company's weight loss obesity ...
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, ...
Novo Nordisk A/S won approval to sell a pill version of its obesity shot Wegovy in the US. Novo will start ...
Zohran Mamdani was elected the 111th mayor of New York in a historic victory that will put an avowed democratic ...
Stocks rise ahead of confirmed trade talks between the US and China, a sign that eye-watering tariffs between the world's ...
Volatility is still gripping markets with investors evaluating policy, geopolitical and recession risks; Oil holds gains amid tensions in the ...
“Bloomberg Brief” delivers the market news, data and analysis you need to set your agenda. Today's guests: Valentin Marinov, Credit ...
“Bloomberg Brief” delivers the market news, data and analysis you need to set your agenda. Today's guests: Keith Learner, Truist ...
“Bloomberg Brief” delivers the market news, data and analysis you need to set your agenda. Today's guests: Peter Kinsella, Union ...
Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.
Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.